• Eliminating Pollen Interference in Hazardous Bioaerosol Dete

  2026-06-12

  This study introduces an advanced spectral transformation and machine learning approach to accurately classify hazardous bioaerosols by removing pollen-induced interference. The findings provide a robust methodological advance for rapid, reliable detection of pathogenic bacteria and toxins in complex airborne environments.

• PRC2 Inhibition Enables Naive Pluripotent Stem Cell Self-Ren

  2026-06-12

  Huang et al. (2025) demonstrate that inhibiting the Polycomb repressive complex 2 (PRC2) overcomes a key barrier to propagating naive pluripotent stem cells (PSCs) from chimpanzee, enabling robust self-renewal and blastoid formation. This advance provides a comparative model for early primate embryogenesis and informs protocols for human PSC expansion.

• E. coli Uracil-DNA Glycosylase (UDG): Technical Workflow Gui

  2026-06-11

  E. coli Uracil-DNA Glycosylase (UDG) addresses uracil-mediated DNA contamination in PCR and DNA repair research workflows by excising uracil residues from DNA. It is strictly intended for scientific research use on DNA substrates and is not suitable for RNA, oligonucleotides shorter than six bases, or clinical applications.

• Rotigotine Hydrochloride: Analytical Integrity and Translati

  2026-06-11

  Explore the pivotal role of Rotigotine hydrochloride as a dopamine D2/D3 receptor agonist in Parkinson's disease research. This article offers a distinctive focus on analytical quality, impurity profiling, and stability—critical for robust dopaminergic signaling research and advanced neurodegenerative disease modeling.

• Metabolomics Signatures of Carbapenem Resistance in Enteroba

  2026-06-10

  This study applies LC-MS/MS metabolomics and machine learning to rapidly distinguish carbapenemase-producing Enterobacterales (CPE) from non-CPE strains. The identification of metabolic biomarkers for resistance enables earlier detection of CPE and provides mechanistic insight into bacterial adaptation, with implications for diagnostics and antimicrobial research.

• GKT137831: Dual NADPH Oxidase Nox1/Nox4 Inhibitor in Redox R

  2026-06-10

  GKT137831 uniquely enables precise inhibition of Nox1 and Nox4-driven oxidative stress, making it indispensable for advanced redox modulation in vascular and fibrotic disease models. This guide delivers actionable workflow enhancements, troubleshooting insights, and direct translational benchmarks from the latest literature.

• Phosphatase Inhibitor Cocktail 3 (100X in DMSO): Protocol an

  2026-06-09

  Phosphatase Inhibitor Cocktail 3 (100X in DMSO) is designed for the preservation of protein phosphorylation states during cell and tissue lysate preparation, crucial for accurate downstream phosphoprotein analyses. It is not suitable for workflows that require the activity of phosphatases, nor for applications incompatible with DMSO or its component inhibitors.

• Ibotenic Acid: NMDA Receptor Agonist in Neurodegenerative Mo

  2026-06-09

  Ibotenic acid empowers precision modeling of neurodegenerative disorders by leveraging its NMDA receptor agonism and robust solubility profile. This article distills protocol insights, highlights troubleshooting strategies, and translates the latest in vivo toxicology findings into actionable advances for neuroscience researchers.

• U-73122: Applied Workflows for Phospholipase C Inhibitor Res

  2026-06-08

  U-73122 empowers researchers to dissect the PLC signaling pathway with precise control over calcium flux and chemotaxis, enabling robust designs for apoptosis and inflammation studies. This article delivers protocol-focused guidance, real-world troubleshooting, and comparative insights, all grounded in recent translational research.

• hiPSC-Derived Intestinal Organoids for CYP2C19 Substrate Stu

  2026-06-08

  This study introduces a streamlined protocol for generating human induced pluripotent stem cell (hiPSC)-derived intestinal organoids, providing a robust in vitro model for pharmacokinetic analysis of orally administered drugs. The work demonstrates enhanced relevance for cytochrome P450 metabolism studies, particularly for evaluating CYP2C19 substrates, and addresses key limitations of traditional models.

• Cefiderocol Activity vs. Resistant Enterobacterales: Insight

  2026-06-07

  The reference study systematically evaluated the in vitro efficacy of cefiderocol against a large European Enterobacterales collection, including strains resistant to meropenem and novel β-lactam/β-lactamase inhibitor combinations. Its findings highlight cefiderocol's superior susceptibility rates, directly informing antimicrobial resistance modeling and antibiotic selection strategies—especially relevant for research on Gram-negative CNS infections.

• Genotyping Kit for Target Alleles: Precision DNA Prep Unveil

  2026-06-06

  Discover how the Genotyping Kit for target alleles of insects, tissues, fishes and cells revolutionizes PCR amplification and single-tube DNA extraction. This article uniquely explores mechanistic precision, assay design, and the latest scientific insights for molecular biology genotyping research.

• L-Alanyl-L-Glutamine: Technical Guide for GI Barrier Researc

  2026-06-05

  L-Alanyl-L-Glutamine (B8228) addresses the challenge of maintaining intestinal barrier integrity and nutrient stability in GI research models. This compound is best utilized where conventional glutamine is unstable or insufficient for antioxidant and mucosal protection workflows. It is not suitable for protocols requiring solubility in DMSO or ethanol.

• Oxaliplatin: Mechanism, Benchmarks, and Preclinical Standard

  2026-06-05

  Oxaliplatin is a platinum-based chemotherapeutic agent that induces apoptosis through DNA adduct formation. It demonstrates potent cytotoxicity in colorectal and other cancers, with established dosing protocols and recognized limits in model reliability. This article synthesizes recent evidence and best practices for integrating Oxaliplatin into cancer research workflows.

• Optimizing Cell Assays with EZ Cap™ Cy5 EGFP mRNA (5-moUTP)

  2026-06-04

  This article addresses persistent challenges in cell viability, proliferation, and cytotoxicity assays, emphasizing how EZ Cap™ Cy5 EGFP mRNA (5-moUTP) (SKU R1011) delivers reproducible, quantitative solutions. Scenario-driven Q&A blocks guide researchers through workflow optimization, data interpretation, and reliable vendor selection, grounded in peer-reviewed evidence and APExBIO’s validated product design.

16974 records 1/1132 page Next 12345 下5页 Last page